Physician profile
Anna E Sweeney
NPI 1760807721
$1,813.98
in general payments reported to CMS, 2019-2025
15 companies · $556 in 2025
The $556 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $183 · 2022: $370 · 2023: $390 · 2024: $316 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,261.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $551.52 | 2023-2025 | Dupixent, Libtayo |
| Alk-Abello, INC | $294.20 | 2021-2022 | |
| Glaxosmithkline, LLC. | $226.15 | 2023-2025 | Nucala |
| Genzyme Corporation | $218.07 | 2022-2024 | |
| Optinose US, INC. | $155.55 | 2021-2025 | |
| Stryker Corporation | $96.56 | 2021-2025 | Scopis Ent |
| Pharmacyclics LLC, An Abbvie Company | $61.00 | 2022-2023 | Imbruvica |
| Kaleo, INC. | $46.83 | 2022-2023 | Auvi-Q |
| Hikma Pharmaceuticals USA | $46.35 | 2023-2025 | Ryaltris |
| Hologic Sales and Service, LLC | $22.88 | 2023 | Coolseal Generator |
| Inspire Medical Systems, INC. | $21.20 | 2025 | Inspire |
| Intersect Ent, INC. | $19.76 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $19.73 | 2025 | Neffy |
| Amgen INC. | $19.57 | 2024 | Tavneos |
| Phadia US INC. | $14.61 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.